Project Details
Description
A PHASE 1, FIRST IN HUMAN, DOSE-ESCALATION STUDY OF TORL-1-23 IN PARTICIPANTS WITH ADVANCED CANCER
Status | Active |
---|---|
Effective start/end date | 4/1/22 → 1/1/26 |
Funding
- TORL BIOTHERAPEUTICS, LLC
Project: Research project
Status | Active |
---|---|
Effective start/end date | 4/1/22 → 1/1/26 |